Lovastatin Acid

HCID 64727CAS 75225-51-3

Basic information

Standard SMILES
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21
InChIKey
QLJODMDSTUBWDW-BXMDZJJMSA-N
Molecular formula
C24H38O6
Average molar mass
422.6 g/mol
Monoisotopic mass
422.26683894

Overview

Mevinolinic acid is a polyketide obtained by hydrolysis of the pyranone ring of lovastatin. It has a role as an EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor, a drug metabolite, a teratogenic agent and an Aspergillus metabolite. It is a polyketide, a fatty acid ester, a dihydroxy monocarboxylic acid and a carbobicyclic compound. It is functionally related to a (S)-2-methylbutyric acid and a lovastatin. It is a conjugate acid of a mevinolinate.

Names & identifiers

Preferred name
Lovastatin Acid
IUPAC
(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
English name
LOVASTATIN HYDROXY ACID, SODIUM SALT
Molecular formula
C24H38O6
Molecular weight
422.55

Names & synonyms

Lovastatin acidMevinolinic acid75225-51-3Monacolinic K acidMSD 803 acidMK 819L-154819MK-819MSD-803 ACID5CLV35Y90C(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid(3R,5R)-7-[(1S,2S,6R,8S,8aR)-2,6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
Show more names
mk819MB 530Bl154819msd803acidmsd803freeacidmonacolinickacidLOVASTATIN SODIUMmevinolinicacidammoniumsaltLovastatin-d9 hydroxy sodium6-beta,8-beta(r*),8a-beta))-2-alpha
CHEBI:82985DTXSID20873334lovestatin acid(3R,5R)-7-((1S,2S,6R,8S,8aR)-2,6-dimethyl-8-(((2S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid(3R,5R)-7-((1S,2S,6R,8S,8aR)-2,6-dimethyl-8-((2S)-2-methylbutanoyl)oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acidRefChem:818793DTXCID70820838L-154,819

Database identifiers

CAS
75225-51-3
PubChem CID
64727
DTXSID
DTXSID20873334
ChEMBL
CHEMBL1201373
ChEBI
CHEBI:82985
UNII
5CLV35Y90C
Nikkaji
J399.042G

Properties

Computed structural properties

XLogP
3.5
Topological polar surface area
104 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
6
Rotatable bonds
11
Heavy atoms
30

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Melting point
140 · 140 - 143oC
Boiling point
602.3 · 602.3±55.0 °C(Predicted)
Density
1.14 · 1.14±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility
DMSO (Slightly), Methanol (Slightly, Sonicated), Water (Slightly)
form
Solid

Safety & regulation

Safety data

Signal word
Warning
Symbol(GHS)
GHS08
Hazard statements
H351-H361f-H413
Precautionary statements
P202-P273-P280-P308+P313-P405-P501

Chemistry & industry

Applications

UsesLovastatin Hydroxy Acid, Sodium Salt (Lovastatin EP Impurity B) is a metabolite of Lovastatin.

Suppliers6 total

BOC Sciences1-631-485-4226; 16314854226 · [email protected]
长沙晶康新材料科技有限公司0733-0731-85118349 18229890050 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
BOC Sciences16314854226 · [email protected]
TargetMol中国(陶术生物)15002134094 · [email protected]

Additional notes

DefinitionChEBI: A polyketide obtained by hydrolysis of the pyranone ring of lovastatin.

Related reactions

5 records

Linked notes

Loading…